Performance of p16INK4a immunocytochemistry as a marker of anal squamous intraepithelial lesions

Cancer Cytopathology

Volumn 119, Issue 3, 2011, Pages 167-176

  Da Costa e Silva, Ivan Tramujas ^a,b   Ribeiro, Michelle Coelho ^a   Gimenez, Felicidad Santos ^a   Ferreira, Junia Raquel Dutra ^a   Galvao, Renata Silva ^c   Hargreaves, Paula Emanuelle Vasco ^c   Guimaraes, Adriana Goncalves Daumas Pinheiro ^b   De Lima Ferreira, Luiz Carlos ^c  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c Tropical Medicine Foundation of Amazonas   (Brazil)

Author keywords

Anal neoplasms; Diagnosis; Genes; Immunocytochemistry; P16; Precancerous conditions; Sensitivity; Specificity

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PRESERVATIVE; TUMOR MARKER;

ADULT; AGED; ANAL SQUAMOUS INTRAEPITHELIAL LESION; ARTICLE; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; FEMALE; GENOTYPE; HIGH RESOLUTION ANOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRECANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECTUM BIOPSY; SENSITIVITY AND SPECIFICITY; WART VIRUS; ADOLESCENT; ANUS TUMOR; CROSS-SECTIONAL STUDY; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80051641187     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20143     Document Type: Article

References (40)

1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101:281-288.
2. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet. 1991;338:657-659.
3. Palefsky JM, Cranston RD. Anal intraepithelial neoplasia: Diagnosis, screening and treatment [UpToDate Website]. March 9, 2009. http://www.uptodate. com/online/content/ topic.do?topicKeytumorhiv/2317. Accessed April 2, 2009.
4. Medical Advisory Secretariat. Anal dysplasia screening: Evidence based analysis. Ontario Health Technology Assessment Series. Toronto, Ontario: Ministry of Health and Long Term Care; 2007;7:1-45. http://www.health.gov.on. ca/english/providers/program/mas/tech/reviews/pdf/rev-ads-20070919.pdf. Accessed June 6, 2009.
5. Friedlander MA, Stier E, Lin O. Anorectal cytology as a screening tool for anal squamous lesions: Cytologic, anoscopic, and histologic correlation. Cancer. 2004;102:19-26.
6. de Ruiter A, Carter P, Katz DR, et al. A comparison between cytology and histology to detect anal intraepithelial neoplasia. Genitourin Med. 1994;70:22-25.
7. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:415-422.
8. Lytwyn A, Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer. 2005;103:1447-1456.
9. Fenger C. The anal transitional zone. Location and extent. Acta Pathol Microbiol Scand A. 1979;87A:379-386.
10. Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol. 2008;15:263-278.
11. Gravitt PE, Coutlee F, Iftner T, Sellors JW, Quint WG, Wheeler CM. New technologies in cervical cancer screening. Vaccine. 2008;26 suppl 10:K42-K52.
12. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis. Cancer Treat Rev. 2009;35:210-220.
13. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. PNAS. 1996;93:4350-4354.
14. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: A reappraisal of its use in cervical biopsies. Pathology. 2008;40:335-344.
15. Guimaraes AGDP. Analise morfometrica das celulas dendriticas na mucosa anal de pacientes HIV positivos e relacao com a lesao intraepitelial e o cancer. [Master's thesis]. Manaus, Brazil: Federal University of Amazonas; 2007. http:// www.ufam.edu.br/-dcc1/Dissert-Guimaraes-UFAM-2007. pdf. Accessed January 19, 2011.
16. Costa e Silva IT, Ferreira LCD, Gimenez FS, et al. Highresolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol. 2008;15: 1470-1475.
17. Synermed. GluCyte. Kit para processo de citologia por camada delgada. Synermed Website 2007. http://www. synermed.com.br/Pdfs/Downloads/Bulas/ glucytekit.pdf. Accessed August 25, 2007.
18. Dry J, Wald-Scott C, Friedberg MA, Knesel BW, Caron L. Comparison of the new Synermed GluCyte liquid-based thin-layer preparation with both Cytyc ThinPrep and Tri-Path SurePath preparations [abstract]. Acta Cytol. 2004;48: 697.
19. Lucey BP, Nelson-Rees WA, Hutchins GM. Henrietta Lacks, HeLa cells, and cell culture contamination. Arch Pathol Lab Med. 2009;133:1463-1467.
20. de Roda Husman AM, Walboomers JM, Hopman E, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The agerelated pattern. J Med Virol. 1995;46:97-102.
21. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
22. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG. PCR detection of human papillomavirus of the mucosa: Comparison between MY09/11 and GP5/6 primer sets. J Clin Virol. 2004;30:302-308.
23. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389-3402.
24. Jekel JF, Katz DR, Elmore JG. Entendendo os erros em medicina clinica. In: Jekel JF, Katz DR, Elmore JG, eds. Epidemiologia, Bioestatistica e Medicina Preventiva. Porto Alegre, RS: Artmed; 2005:117-119.
25. BioEstat [computer program]. Version 5.0. Belem (PA), Brasil: Instituto de Desenvolvimento Sustentavel Mamiraua; 2007. http://www.mamiraua.org.br/ download/download.php? fname./BioEstat%205%20Portugues/BioEstat5.0.rar. Accessed January 31, 2010.
26. Costa e Silva IT, Araujo JR, Andrade RV, et al. Anal cancer precursor lesions in HIV-positive and HIV-negative patients seen at a tertiary health institution in Brazil. Acta Cir Bras. 2011;26:64-71.
27. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIVinfected heterosexual men, homosexual men and women: Prevalence and associated factors. AIDS. 2007;21:1457-1465.
28. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367.
29. Piketty C, Darragh TM, Da C, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138:453-459.
30. Sirera G, Videla S, Pinol M, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS. 2006;20:1201-1204.
31. Costa e Silva IT, Gimenez FS, Guimaraes RA. Anal cytology as a screening method for early detection of anal cancer: Are hydrophilic cotton smears really unsatisfactory [in Portuguese]? Acta Cir Bras. 2005;20:109-114.
32. Gimenez FS, Costa e Silva IT, Guimaraes AGDP, Araujo JR, Medeiros SGGAM, Ferreira LCL. The value of highresolution anoscopy in the diagnosis of anal cancer precursor lesions in HIV-positive patients in Manaus-Amazonas. Arq Gastroenterol. In press.
33. Goldstone SE. High-resolution anoscopy is a crucial component of anal dysplasia screening. Dis Colon Rectum. 2010; 53:364-365.
34. Berry JM, Palefsky JM. Invited commentary. Dis Colon Rectum. 2009;52:1860-1863.
35. Gohy L, Gorska I, Rouleau D, et al. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr. 2008;49:32-39.
36. Darvishian F, Stier EA, Soslow RA, Lin O. Immunoreactivity of p16 in anal cytology specimens: Histologic correlation. Cancer. 2006;108:66-71.
37. Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2008;17:2536-2545.
38. Meyer JL, Hanlon DW, Andersen BT, Rasmussen OF, Bisgaard K. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: Correlation with biopsy follow-up results. Cancer. 2007;111:83-92.
39. Wentzensen N, Bergeron C, Cas F, Eschenbach D, Vinokurova S, von Knebel DM. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquidbased cytology samples. Cancer. 2005;105:461-467.
40. Wentzensen N, Bergeron C, Cas F, Vinokurova S, von Knebel DM. Triage of women with ASCUS and LSIL cytology: Use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Cancer. 2007;111:58-66.